95251 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
Hetero ring compound and organic light emitting diode comprising same
#1202Inhibitors of plasma kallikrein
#1203Space-through charge transfer compound, and organic light emitting diode and display device using the same
#1204Hydantoins that modulate BACE-mediated APP processing
#1205Organic electroluminescent device
#1206Nitrogen-containing heterocyclic compound
#1207Nitrogen-containing heterocyclic compound
#1208PHENYLIMIDAZOLE DERIVATIVE, AND THERAPEUTIC MEDICINE OR PREVENTIVE MEDICINE FOR INFLAMMATORY DISEASE, ETC.
#1209IDO inhibitors
#1210Nitrogen-containing polycyclic compound and organic electroluminescent device using the same
#1211COMPOUND AND METHODS FOR PREPARING THE SAME AND ITS APPLICATIONS
#1212Hetero ring compound and organic light emitting diode comprising same
#1213Materials for electronic devices
#1214COMPOUND AND METHODS FOR PREPARING THE SAME AND ITS APPLICATIONS
#1215Anti-inflammatory agents
#1216SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS
#1217Organic electroluminescent device
#1218SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY
#1219BICYCLO 2,3-BENZODIAZEPINES AND SPIROCYCLICALLY SUBSTITUTED 2,3-BENZODIAZEPINES
#1220Substituted benzoazepines as toll-like receptor modulators
#1221Indenoindole derivative and organic electroluminescent element
#1222Indole carboxamide compounds
#1223Space-through charge transfer compound, and organic light emitting diode and display device using the same
#1224Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1
#1225Indolinone compounds and uses thereof
#1226Condensed-cyclic compound and organic light-emitting diode including the same
#1227ALKYNYL ALCOHOLS AND METHODS OF USE
#1228Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#1229Materials for organic electroluminescent devices
#1230PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS
#1231Arylquinazolines
#1232COMPOSITIONS AND METHODS FOR HAIR GROWTH
#1233Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1
#1234Materials for electronic devices
#1235Triazolone derivatives or salts thereof and pharmaceutical composition comprising the same
#1236Organic electroluminescent materials and devices
#1237Compound for organic optoelectric device, organic light-emitting diode including same, display device including organic light-emitting diode
#1238Heterocyclic compound for organic electroluminescent device and its application
#1239Kinase inhibitors and method of treating cancer
#1240Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#1241Benzylamine derivatives
#1242GLP-1 receptor modulators
#1243Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
#1244Material for organic electroluminescent device and organic electroluminescent device using same
#1245NAMPT and ROCK inhibitors
#1246Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#1247Antimicrobial compounds and methods of making and using the same
#1248Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#1249Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
#1250Choline kinase inhibitors
#1251Compound, light emitting material, and organic light emitting device
#1252Compounds and compositions for the treatment of cancer
#1253Pyrazole compounds and methods of use thereof
#12541-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties and methods for preparation thereof
#1255Benzamide derivative useful as FASN inhibitors for the treatment of cancer
#1256Hydantoins that modulate bace-mediated app processing
#1257Production method of pyridazinone compounds
#1258COMT inhibitors
#1259Phthalazinone derivatives
#1260Flap modulators
#12612-aminopyrazine derivatives as CSF-1R kinase inhibitors
#1262Condensed fluoranthene compound, organic electroluminescence element material including same, organic electroluminescence element using same, and electronic device
#1263Phthalazinones and isoquinolinones as rock inhibitors
#1264Antiproliferative benzo [B] azepin-2-ones
#1265Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders
#1266Organic electroluminescent materials and devices
#1267Triazolone compounds and uses thereof
#1268Organic electroluminescent element
#1269Resin composition
#1270Materials for organic electroluminescent devices
#12712,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same
#1272Material for organic electronic device, and organic electronic device using the same
#1273Piezoelectric-based multiple impact sensors and their electronic circuitry
#1274Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
#1275Aromatic amine derivative and organic electroluminescent element
#1276Hepatitis C virus inhibitors
#1277Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
#1278Materials for organic electroluminescent devices
#1279Amino-pyrimidine skeletal muscle modulators
#1280Bicyclic heterocyclic compound containing a substituted pyrrole ring
#1281Nitrogen-containing heterocyclic compound
#1282Condensed cyclic compound and organic light-emitting device including the same
#1283Compounds for use in the treatment of parasitic diseases
#1284RORgammaT inhibitors
#1285Substituted phthalazin-1 (2H)-one derivatives as selective inhibitors of poly (ADP-ribose) polymerase-1
#1286Tricyclic compound
#12874,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
#1288Benzoazepine derivative and medical use thereof
#1289ROR modulators and their uses
#1290Substituted cinnolines as inhibitors of LRRK2 kinase activity
#1291Triazolone compounds as mPGES-1 inhibitors
#1292Thermally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same
#1293Heterocyclic compound
#12945H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
#1295Compounds for inflammation and immune-related uses
#1296FLAP modulators
#1297Five-membered heterocycles useful as serine protease inhibitors
#1298Antibacterial protein kinase inhibitors
#1299Nitrogen-containing heterocyclic derivative, organic electroluminescence element material using same, and organic electroluminescence element and electronic device using same
#1300Hematopoietic growth factor mimetic small molecule compounds and their uses
#1301Pyrazole derivative
#1302Organic electroluminescent materials and devices
#1303MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES
#1304Deprotection method for tetrazole compound
#1305Method for producing biaryl compound
#1306Quinazolinone derivatives as PARP inhibitors
#1307Methods of pest control in soybean
#1308Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
#1309Carbazole-based compound and organic light-emitting device including the same
#1310Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device
#1311Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#1312Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
#1313Dihydropyrimidin-2(1H)-one compounds as -nitrosoglutathione reductase inhibitors
#1314NOVEL AROMATIC HETEROCYCLIC DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL SOLUTION, AND ORGANIC ELECTROLUMINESCENT ELEMENT
#1315Materials for organic electroluminescent devices
#1316Heterocyclic modulators of lipid synthesis
#1317Quinone compounds and their uses for the treatment of cancer
#1318Method and manufacturing system
#13192,3-benzodiazepines
#1320Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative
#1321Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#1322N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereof
#1323Dual-acting imidazole antihypertensive agents
#1324METHODS OF CONTROLLING INSECTS
#1325Carbazole compound and organic light-emitting device including the same
#1326Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
#1327Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
#1328TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
#1329Inhibition of bacterial biofilms with imidazole-phenyl derivatives
#1330Carbazole compound and organic light-emitting device including the same
#1331Modulators of calcium release-activated calcium channel
#1332Heterocyclic compound and organic electronic element containing same
#1333Graphene nanoribbons with controlled modifications
#1334Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
#1335Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyrdazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
#1336N-biphenylmethylbenzimidazole modulators of PPARG
#1337Pyridine and piperidine derivatives as novel sodium channel blockers
#1338Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
#1339Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase
#1340Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#1341Triazole compounds that modulate HSP90 activity
#1342Heterocyclic compound and use therefor
#1343Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
#1344Modulators of the relaxin receptor 1
#1345Azetidine derivatives as antiparasitic agents
#1346Chrysene-based compound and organic light-emitting device including the same
#1347Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
#1348DNA-PK inhibitors
#1349Estrogen receptor modulators and uses thereof
#1350Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
#1351Heterocyclic aspartyl protease inhibitors
#1352Polyphenylene host compounds
#1353Carboxylic acid compounds
#1354Pyrene-based compound and organic light-emitting device including the same
#1355Heterocyclic compound and organic light-emitting device comprising same
#1356Triazolone compounds as mPGES-1 inhibitors
#1357Phenyl and benzodioxinyl substituted indazoles derivatives
#1358Triazolone compounds and uses thereof
#1359Organic electroluminescent element, organic electroluminescent lighting device and organic electroluminescent display device
#1360Organic compound, charge-transporting material, composition containing the compound, organic electroluminescent element, display device, and lighting device
#1361Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides
#1362ROR modulators and their uses
#1363Condensed-cyclic compound and organic light-emitting device comprising the same
#1364Diarylhydantoin compounds
#1365Dual-acting antihypertensive agents
#1366HIGHLY 6-SUBSTITUTED -2,4-DIAMINOPYRIMIDINES AS INHIBITORS OF ANTHRAX
#1367ALKYNYL ALCOHOLS AND METHODS OF USE
#1368ALKYNYL ALCOHOLS AND METHODS OF USE
#1369Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#1370Oxime Ester Photoinitiators
#1371Antiviral compounds and uses thereof
#1372Organic electroluminescent materials and devices
#1373Large substituent, non-phenolic opioids and methods of use thereof
#1374Substituted pyrazines as ATR kinase inhibitors
#1375Compound, light-emitting material, and organic light-emitting device
#1376Anthracene-based compounds and organic light-emitting device including the same
#1377INDOLE AND INDAZOLE COMPOUNDS THAT ACTIVATE AMPK
#1378Anti-malarial agents
#1379Cyclic amides as MetAP-2 inhibitors
#1380Substituted pyrazin-2-amines as inhibitors of ATR kinase
#1381NOVEL TRIAZINE DERIVATIVE
#1382Pyridazinone derivatives
#1383GLP-1 receptor modulators
#1384Indazole derivatives
#1385Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative
#1386Organic electroluminescent materials and devices
#1387Substituted tetrahydrocarbazole and carbazole carboxamide compounds
#13885-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
#1389Benzimidazole derivatives as PI3 kinase inhibitors
#13902-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
#1391Phthalazinone derivatives
#1392Aromatic amine derivative and organic electroluminescence element using same
#1393NOVEL TRIAZINEDIONE DERIVATIVES AS GABAB RECEPTOR MODULATORS
#1394Indazole compounds as kinase inhibitors and method of treating cancer with same
#1395Protein kinase inhibitors
#1396Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides
#1397Indazole compounds useful as ketohexokinase inhibitors
#1398Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
#1399Aryl triazole compounds with antitumoural activity
#1400Metathesis catalysts and methods thereof
#1401Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
#1402Inhibiting G protein coupled receptor 6 kinase polypeptides
#1403Organic electroluminescence element, and material for organic electroluminescence element
#1404Heteroaryl-based compound and organic light-emitting diode including the same
#1405Dual-acting imidazole antihypertensive agents
#1406(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors
#1407Heterocyclic compound and organic electronic element containing same
#1408Dihydropyrazoles
#1409Inhibitors of the renal outer medullary potassium channel
#1410Anti-infective agents and uses thereof
#1411Heterocyclic compound and organic light-emitting device including the same
#1412Mono-fluoro beta-secretase inhibitors
#1413N-ARYLYLMETHYLINDAZOLE MODULATORS OF PPARG
#1414Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1
#14152-thiopyrimidinones
#1416Articles and methods comprising persistent carbenes and related compositions
#1417Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#1418Pyrrole-3-carboxamide bromodomain inhibitors
#1419SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS
#1420Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#1421Azole derivative
#1422Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
#1423Pyrazole derivatives as protein kinase modulators
#1424Pyrazole azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#1425Azetidinyl diamides as monoacylglycerol lipase inhibitors
#1426COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
#1427Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
#1428Anti-infective agents and uses thereof
#1429Inhibitors of the renal outer medullary potassium channel
#1430Substituted benzoazepines as toll-like receptor modulators
#1431Method of treatment or prophylaxis
#1432Flap modulators
#1433Viral replication inhibitors
#14341,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#1435Inhibitors of poly(ADP-ribose)polymerase
#1436Methods for preparing oxazolidinones and compositions containing them
#1437Certain amino-pyrimidines, compositions thereof, and methods for their use
#1438Five-membered heterocycles useful as serine protease inhibitors
#1439Substituted phthalazinones as rock inhibitors
#1440Substituted 4-(1H-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of mAChR Mreceptors
#1441Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-hydrochloride salt and processes of manufacturing thereof
#1442Substituted 1-benzylindolin-2-one analogs as positive allosteric modulators of muscarinic acetylcholine M1 receptors
#1443Pyrazolyl-based carboxamides I
#1444Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#1445Carbazole derivatives and organic light-emitting diode device using the same
#1446ENHANCEMENT OF CELLULAR TRANSPLANTATION USING SMALL MOLECULE MODULATORS HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
#1447Light-emitting devices comprising emissive layer
#1448Pyrene-based compound and organic light-emitting diode including the same
#1449Bipolar hosts for light emitting devices
#1450PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN ASSOCIATED WITH GUILLAIN-BARRE SYNDROME
#1451Organic light emitting host materials
#1452Organic electroluminescent materials and devices
#1453Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#1454Amine derivative, organic electroluminescence material having the same and organic electroluminescence device using the material
#1455Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
#1456Pyridazinone derivatives
#1457Benzimidazole derivatives as PI3 kinase inhibitors
#1458Carbocyanines for G-quadruplex DNA stabilization and telomerase inhibition
#1459Substituted benzoazepines as toll-like receptor modulators
#1460Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
#1461METHOD FOR TREATING INFLAMMATORY DISORDERS
#1462Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
#1463Substituted aromatic oligomers
#1464Substituted sulfonamides useful as antiapoptotic Bcl inhibitors
#1465Pyrimidinyl pyridazinone derivatives
#1466Heterocyclic compound and organic light emitting device including the same
#1467Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents for Liver Toxicity
#1468Pyrrole inhibitors of S-nitrosoglutathione reductase
#1469Pyrazole compounds as CRTH2 antagonists
#1470Dual-acting benzoimidazole antihypertensive agents
#1471Compounds as S-Nitrosoglutathione Reductase Inhibitors
#1472Imidazole compounds that modulate HSP90 activity
#1473Pyrazole derivative
#1474Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
#1475Aminomethyl biaryl benzotriazole derivatives
#1476Substituted benzoazepines as toll-like receptor modulators
#1477Androgen receptor antagonists and uses thereof
#1478Compounds for use in light emitting devices
#1479Heterocyclic aspartyl protease inhibitors
#1480KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
#14811,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#1482PROSTATE CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS
#1483Pesticidal arylpyrrolidines
#1484DNA-PK inhibitors
#1485Kinase inhibitors and method of treating cancer
#1486Imidazole based LXR modulators
#1487RORgammaT inhibitors
#1488WNT protein signalling inhibitors
#1489Organic compound, charge-transporting material, composition containing the compound, organic electroluminescent element, display device, and lighting device
#1490Quinazolinediones and their use
#1491Protein kinase inhibitors
#1492Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
#1493Insecticidal arylpyrrolines
#1494Kinase inhibitors and method of treating cancer with same
#1495Compounds for the treatment of proliferative disorders
#1496Pyridinone and pyridazinone derivatives
#1497Organic electroluminescent element
#1498Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
#1499Modulators of calcium release-activated calcium channel
#1500Compounds for inflammation and immune-related uses